Sökning: onr:"swepub:oai:lup.lub.lu.se:1d2d69dd-2ce7-4bba-b4ef-1604476f8231" > Non-Lymphoma Hemato...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04038naa a2200601 4500 | |
001 | oai:lup.lub.lu.se:1d2d69dd-2ce7-4bba-b4ef-1604476f8231 | |
003 | SwePub | |
008 | 160401s2013 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/42041622 URI |
024 | 7 | a https://doi.org/10.1159/0003501652 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Lu, Mary4 aut |
245 | 1 0 | a Non-Lymphoma Hematological Malignancies in Systemic Lupus Erythematosus |
264 | c 2013-10-02 | |
264 | 1 | b S. Karger AG,c 2013 |
520 | a Objective: To describe non-lymphoma hematological malignancies in systemic lupus erythematosus (SLE). Methods: A large SLE cohort was linked to cancer registries. We examined the types of non-lymphoma hematological cancers. Results: In 16,409 patients, 115 hematological cancers [including myelodysplastic syndrome (MDS)] occurred. Among these, 33 were non-lymphoma. Of the 33 non-lymphoma cases, 13 were of lymphoid lineage: multiple myeloma (n = 5), plasmacytoma (n = 3), B cell chronic lymphocytic leukemia (B-CLL; n = 3), precursor cell lymphoblastic leukemia (n = 1) and unspecified lymphoid leukemia (n = 1). The remaining 20 cases were of myeloid lineage: MDS (n = 7), acute myeloid leukemia (AML; n = 7), chronic myeloid leukemia (CML; n = 2) and 4 unspecified leukemias. Most of these malignancies occurred in female Caucasians, except for plasma cell neoplasms (4/5 multiple myeloma and 1/3 plasmacytoma cases occurred in blacks). Conclusions: In this large SLE cohort, the most common non-lymphoma hematological malignancies were myeloid types (MDS and AML). This is in contrast to the general population, where lymphoid types are 1.7 times more common than myeloid non-lymphoma hematological malignancies. Most (80%) multiple myeloma cases occurred in blacks; this requires further investigation. (C) 2013 S. Karger AG, Basel | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Systemic lupus erythematosus | |
653 | a Malignancy | |
653 | a Cancer | |
700 | 1 | a Bernatsky, Sasha4 aut |
700 | 1 | a Ramsey-Goldman, Rosalind4 aut |
700 | 1 | a Petri, Michelle4 aut |
700 | 1 | a Manzi, Susan4 aut |
700 | 1 | a Urowitz, Murray B.4 aut |
700 | 1 | a Gladman, Dafna4 aut |
700 | 1 | a Fortin, Paul R.4 aut |
700 | 1 | a Ginzler, Ellen M.4 aut |
700 | 1 | a Yelin, Edward4 aut |
700 | 1 | a Bae, Sang-Cheol4 aut |
700 | 1 | a Wallace, Daniel J.4 aut |
700 | 1 | a Jacobsen, Soren4 aut |
700 | 1 | a Dooley, Mary Anne4 aut |
700 | 1 | a Peschken, Christine A.4 aut |
700 | 1 | a Alarcon, Graciela S.4 aut |
700 | 1 | a Nived, Olau Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)reum-oni |
700 | 1 | a Gottesman, Lena4 aut |
700 | 1 | a Criswell, Lindsey A.4 aut |
700 | 1 | a Sturfelt, Gunnaru Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)reum-gst |
700 | 1 | a Dreyer, Lene4 aut |
700 | 1 | a Lee, Jennifer L.4 aut |
700 | 1 | a Clarke, Ann E.4 aut |
710 | 2 | a Reumatologi och molekylär skelettbiologib Sektion III4 org |
773 | 0 | t Oncologyd : S. Karger AGg 85:4, s. 235-240q 85:4<235-240x 1423-0232x 0030-2414 |
856 | 4 | u http://dx.doi.org/10.1159/000350165y FULLTEXT |
856 | 4 | u https://www.karger.com/Article/Pdf/350165 |
856 | 4 8 | u https://lup.lub.lu.se/record/4204162 |
856 | 4 8 | u https://doi.org/10.1159/000350165 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.